We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Executive summary of the quality assurance (QA) visit to the Cheshire and Merseyside NHS abdominal aortic aneurysm screening programme on 30 January 2020.
This document (RCE-3) presents the conclusions of a review of the basis for establishing health-based protection criteria in the areas of chemicals, ionising radiation, and non-ionising radiation.
Information for health and emergency professionals involved in chemical incident response and preparedness.
Article titles, authors, keywords and links for Chemical Hazards and Poisons Report, published 2003 onward, and the Chemical Incident Report, published 1999 to 2003.
Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing LA and NHS commissioned chlamydia tests.
Guidance to help the commissioning of chlamydia screening, that young people will access via the internet.
Executive summary of quality assurance (QA) visit to Bristol and Weston held on 15 and 16 January 2019.
Executive summary of quality assurance (QA) visit to Bridgewater Community Healthcare NHS Foundation Trust held on 17 April 2019.
Executive summary of the quality assurance (QA) visit to the Calderdale, Kirklees and Wakefield NHS bowel cancer screening programme on 27 and 28 November 2019.
Produced in partnership with the Local Government Association, Universities and Colleges Employers Association and the Faculty of Public Health.
Recommended process for contacting fathers-to-be to offer screening for sickle cell and thalassaemia.
Executive summary of quality assurance (QA) visit to Chelsea and Westminster Hospital NHS Foundation Trust held on 25 April 2018.
This document sets out guidance for commissioning care services for people with sickle cell disease, thalassaemia and other haemoglobin conditions.
A joint guidance statement from the Committees on carcinogenicity, on toxicity, and on mutagenicity of chemicals in food, consumer products and the environment (COC, COT, COM).
Executive summary of quality assurance (QA) visit to Leeds Teaching Hospitals NHS Trust on 14 June 2017.
For midwives to advise pregnant women considering a home birth using a type of birthing pool that carries a risk of Legionnaires’ disease.
The work by PHE to establish the central Whole Genome Sequencing (WGS) service and the transformation of a national bacteriology reference laboratory.
This document (RCE-12) explains the application of the 2007 International Commission on Radiological Protection (ICRP) recommendations.
A summary of research and good practice in bystander interventions.
Guidance on commissioning and providing injectable opioid treatment for people with opioid dependence who have not responded to oral treatment.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).